Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis

Strathdee, 2001, Sex differences in risk factors for HIV seroconversion among injection drug users: a 10-year perspective, Arch Intern Med, 161, 1281, 10.1001/archinte.161.10.1281

Kral, 2001, Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk factor analysis, Lancet, 357, 1397, 10.1016/S0140-6736(00)04562-1

Centers for Disease Control and Prevention, 2010, High-Impact HIV Prevention: CDC’s Approach to Reducing HIV Infections in the United States

Mathers, 2008, for the 2007 Reference Group to the UN on HIV and Injecting Drug Use. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review, Lancet, 372, 1733, 10.1016/S0140-6736(08)61311-2

Mathers, 2010, HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage, Lancet, 375, 1014, 10.1016/S0140-6736(10)60232-2

Gibson, 2001, Effectiveness of syringe exchange programs in reducing HIV risk behaviour and HIV seroconversion among injecting drug users, AIDS, 15, 1329, 10.1097/00002030-200107270-00002

Wodak, Effectiveness of Sterile Needle and Syringe Programming in Reducing HIV/AIDS Among Injecting Drug Users

Monterroso, 2000, Prevention of HIV infection in street-recruited injection drug users, J AIDS, 25, 63

Des Jarlais, 2005, HIV incidence among injection drug users in New York City, 1990 to 2002: Use of serologic test algorithm to assess expansion of HIV prevention services, Am J Public Health, 95, 1439, 10.2105/AJPH.2003.036517

Palmateer, 2010, Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews, Addiction, 105, 844, 10.1111/j.1360-0443.2009.02888.x

McArthur, 2013, Interventions to prevent HIV and hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness, Int J Drug Policy

Jones, 2010, Optimal provision of needle and syringe programmes for injecting drug users: A systematic review, Int J Drug Policy, 21, 335, 10.1016/j.drugpo.2010.02.001

Hong, 2009, HIV/AIDS behavioural interventions in China: a literature review and recommendation for future research, AIDS Behavior, 13, 603, 10.1007/s10461-008-9483-0

Tilson, 2007, Preventing HIV Infection Among Injecting Drug Users in High Risk Countries: An Assessment of the Evidence

Kelly, 2002, Methodological Problems in Constructing the Evidence Base in Public Health

GRADE Working Group, 2004, Grading quality of evidence and strength of recommendations, BMJ, 328, 1

Strathdee, 1997, Needle exchange is not enough: lessons from the Vancouver injecting drug use study, AIDS, 11, F59, 10.1097/00002030-199708000-00001

Amundsen, 2003, Legal access to needles and syringes/needle exchange programmes versus HIV counselling and testing to prevent transmission of HIV among intravenous drug users, Eurn J Public Health, 13, 252, 10.1093/eurpub/13.3.252

Singer, 1997, Changing the environment of AIDS risk: Findings on syringe exchange and pharmacy sales of syringes in Hartford, CT, Med Anthropol, 18, 107, 10.1080/01459740.1997.9966152

Van Ameijden, 1992, The harm reduction approach and risk factors for human immunodeficiency virus (HIV) seroconversion in injecting drug users, Amsterdam, Am J Epidemiol, 136, 236, 10.1093/oxfordjournals.aje.a116489

Wood, 2007, Frequent needle exchange use and HIV incidence in Vancouver, Canada, Am J Med, 120, 172, 10.1016/j.amjmed.2006.02.030

Schechter, 1999, Do needle exchange programmes increase the spread of HIV among injection drug users? An investigation of the Vancouver outbreak, AIDS, 13, F45, 10.1097/00002030-199904160-00002

Bruneau, 1997, High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: Results of a cohort study, Am J Epidemiol, 146, 994, 10.1093/oxfordjournals.aje.a009240

Bruneau, 2011, Trends in human immunodeficiency virus incidence and risk behavior among injection drug users in Montreal, Canada: A 16-year longitudinal study, Am J Epidemiol, 173, 1049, 10.1093/aje/kwq479

Kerr, 2010, Syringe sharing and HIV incidence among injection drug users and increased access to sterile syringes, Am J Public Health, 100, 1449, 10.2105/AJPH.2009.178467

Van den Berg, 2007, Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users, Addiction, 102, 1454, 10.1111/j.1360-0443.2007.01912.x

Valente, 2001, Needle exchange participation, effectiveness, and policy: syringe relay, gender, and the paradox of public health, J Urban Health, 78, 340, 10.1093/jurban/78.2.340

Schoenbaum, 1996, Needle exchange use among a cohort of injecting drug users, AIDS, 10, 1729, 10.1097/00002030-199612000-00018

Des Jarlais, 1996, HIV incidence among injecting drug users in New York City syringe-exchange programmes, Lancet, 348, 987, 10.1016/S0140-6736(96)02536-6

Mansson, 2000, Continued transmission of hepatitis B and C viruses, but no transmission of human immunodeficiency virus among intravenous drug users participating in a syringe/needle exchange program, Scand J Infect Diss, 32, 253, 10.1080/00365540050165875

Patrick, 1997, Determinants of HIV seroconversion in injection drug users during a period of rising prevalence in Vancouver, Int J STD AIDS, 8, 437, 10.1258/0956462971920497

Zhang, 1998, Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy, N Engl J Med, 339, 1803, 10.1056/NEJM199812173392502

Rychetnik, 2002, Criteria for evaluating evidence on public health interventions, J Epidemiol Community Health, 56, 119, 10.1136/jech.56.2.119